PharmaPoint : Atopic Dermatitis US, UK And China Drug Forecast and Market Analysis to 2022

Researchmoz presents this most up-to-date research on "PharmaPoint : Atopic Dermatitis US, UK And China Drug Forecast and Market Analysis to 2022".The report focuses primarily on quantitative market metrics in order to characterize the growth and evolution of the Remote Patient Monitoring Market.

PharmaPoint: Atopic Dermatitis - US Drug Forecast and Market Analysis to 2022 http://www.researchmoz.us/pharmapoint-atopic-dermatitis-us-drug-forecast-and-market-analysis-to-2022-report.html

Although the past decade has seen the atopic dermatitis market remain relatively unchanged and a saturated, highly genericized arena, the coming decade could see the launch of the first biologic, which will set a precedent and pave the way for others to follow suit.

By the mid-to-late term of GlobalDatas 2012 to 2022 forecast, Sanofi/Regenerons dupilumab is expected to reshape the moderate and severe treatment landscape.

Other events that are expected to invoke change to the previously stagnant atopic dermatitis market include the launch of a non-steroidal topical from Anacor, AN2728, generic erosion of branded topicals Protopic and Elidel in the US, and the increasing use of pharmacological treatments in the growing markets of India and China.

The UK , US , China atopic dermatitis market is estimated to have reached $163.0m in 2012 and contributes approximately 13.1% of the total 5EU atopic dermatitis market value. This will primarily be due to strong uptake of systemic vitamin derivatives, but also the increasing uptake of systemic agents, namely methotrexate, antibiotics and corticosteroids.

PharmaPoint: Atopic Dermatitis - UK Drug Forecast and Market Analysis to 2022 http://www.researchmoz.us/pharmapoint-atopic-dermatitis-uk-drug-forecast-and-market-analysis-to-2022-report.html

Scope

Overview of Atopic Dermatitis including epidemiology, etiology, symptoms, diagnosis, pathology and treatment guidelines as well as an overview on the competitive landscape.
Detailed information on the key drugs in the UK , US , China including product description, safety and efficacy profiles as well as a SWOT analysis.
Sales forecast for the top drugs in the UK , US , China from 2012-2022.
Analysis of the impact of key events as well the drivers and restraints affecting the UK , US , China Atopic Dermatitis market.

PharmaPoint: Atopic Dermatitis - China Drug Forecast and Market Analysis to 2022 http://www.researchmoz.us/pharmapoint-atopic-dermatitis-china-drug-forecast-and-market-analysis-to-2022-report.html

Reasons to buy

Understand and capitalize by identifying products that are most likely to ensure a robust return
Stay ahead of the competition by understanding the changing competitive landscape for Atopic Dermatitis
Effectively plan your M&A and partnership strategies by identifying drugs with the most promising sales potential
Make more informed business decisions from insightful and in-depth analysis of drug performance
Obtain sales forecast for drugs from 2012-2022 in the UK , US , China.

For More Information Kindly Contact:
Email: sales@researchmoz.us
WebSite: http://www.researchmoz.us/
Blog: http://globalandchinamarket.blogspot.com
Blog: http://strategicdefenceintelligence.blogspot.com
Blog: http://deepmarketresearchreports.blogspot.com/